CRISPR/Cas9-mediated CysLT1R deletion reverses synaptic failure, amyloidosis and cognitive impairment in APP/PS1 mice
2016 ◽
Vol 13
(9)
◽
pp. 1017-1029
◽
2020 ◽
2000 ◽
Vol 6
(7)
◽
pp. 821-825
◽
Keyword(s):
2017 ◽
Vol 2
(2)
◽
pp. 110-116
Keyword(s):
Keyword(s):
1997 ◽
Vol 103
(1)
◽
pp. 53